Becker's Healthcare March 16, 2023
Noah Schwartz

The FDA has updated its guidance on using EHRs and electronic signatures in clinical trials to account for technological advances since the agency last updated its guidance in 2017, RegulatoryFocus reported March 15.

The updates provide recommendations for applying data integrity and data security tools to clinical trials.

The agency reiterated that sponsors and entities are responsible for ensuring that the records they submit through vendors comply with FDA regulations.

“In addition,...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Clinical Trials, EMR / EHR, FDA, Govt Agencies, Health IT, Technology, Trends
Friday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices
Paxlovid becomes 1st approved COVID-19 pill
FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States
First Ever Topical Gene Therapy Approved For “Butterfly Disease” Children
Withdrawals Of COVID-19 Biologics Should Prompt Us To Reimagine Our Drug Pipeline

Share This Article